MEDFORD, Mass., July 22, 2024 /PRNewswire/ -- YourBio Health, a Boston-based pioneer in remote, capillary whole blood collection technology, announced today that Mark Stevenson has joined the company's Board of Directors. Mr. Stevenson, with his extensive experience in commercializing life sciences and diagnostics innovations globally, is a valuable addition to the Board and will contribute significantly to the company's growth and success..

马萨诸塞州梅德福德，2024年7月22日，波士顿远程毛细血管全血采集技术先驱YourBio Health今天宣布，马克·史蒂文森已加入公司董事会。史蒂文森先生在全球生命科学和诊断创新商业化方面拥有丰富的经验，是董事会的宝贵补充，将为公司的成长和成功做出重大贡献。。

Mr. Stevenson is a Senior Partner at Flagship Pioneering. He recently served as Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific, a company with over $40B in sales and a world leader in serving science through leading its life science solutions, analytical instruments, specialty diagnostics, and laboratory products businesses.

。

He joined Thermo Fisher as Executive Vice President and President of Life Sciences Solutions through the acquisition of Life Technologies. During his tenure, he spearheaded several successful product launches and strategic partnerships, significantly contributing to the company's growth. He has also previously served as President and Chief Operating Officer of Life Technologies and President and Chief Operating Officer of Applied Biosystems prior to its merger with Invitrogen Corporation..

他通过收购Life Technologies加入Thermo Fisher，担任执行副总裁兼生命科学解决方案总裁。在任职期间，他领导了几次成功的产品发布和战略合作，为公司的发展做出了重大贡献。在与Invitrogen Corporation合并之前，他还曾担任Life Technologies的总裁兼首席运营官，以及Applied Biosystems的总裁兼首席运营官。。

'We enthusiastically welcome Mark Stevenson to YourBio Health's Board of Directors,' said Paul Owen, President and CEO of YourBio Health. 'Mark's deep experience optimizing strategy, innovation, and operations in complex, global life sciences business environments will be invaluable to YourBio Health as we grow our business and pursue our mission to improve the blood collection experience for patients.'.

YourBio Health总裁兼首席执行官保罗·欧文（PaulOwen）说，我们热烈欢迎马克·史蒂文森（MarkStevenson）加入YourBio Health董事会Mark在复杂的全球生命科学商业环境中优化战略、创新和运营的丰富经验，将对您的生物健康非常宝贵，因为我们正在发展业务，并致力于改善患者的采血体验。”。

'I am pleased to join YourBio Health to help advance the company's mission of expanding access to its pioneering, virtually painless blood collection technology,' said Mark Stevenson, Board Director of YourBio Health. 'It is an honor to serve alongside my fellow Board members, who share my commitment to this goal.'.

很荣幸能与我的董事会成员一起工作，他们与我一样致力于实现这一目标。”。

To learn more, visit yourbiohealth.com.

要了解更多信息，请访问yourbiohealth.com。

About YourBio HealthYourBio Health is a Flagship Pioneering portfolio company that invented 'Touch-Activated Phlebotomy' (TAP) for virtually painless whole capillary blood collection using devices incorporating patented technology. This technology eliminates barriers to blood collection by allowing a capillary blood sample to be collected from any physical location without the pain of a fingerstick or the need for traditional phlebotomy.

关于YourBio Health YourBio Health是一家旗舰先驱投资组合公司，它发明了“触摸激活静脉切开术”（TAP），使用结合专利技术的设备进行几乎无痛的全毛细血管采血。这项技术通过允许从任何物理位置采集毛细血管血液样本而消除了血液采集的障碍，而无需手指的疼痛或传统的静脉切开术。

Backed by the latest sciences, data management technology, and certified central laboratories, YourBio Health seeks to revolutionize and humanize the blood collection process serving clinical trials, diagnostic and wellness applications..

YourBio Health以最新的科学、数据管理技术和经过认证的中央实验室为支持，致力于为临床试验、诊断和健康应用服务的血液采集过程的革命性和人性化。。

Logo - https://mma.prnewswire.com/media/2461303/YBH_Logo.jpg

Logo-https://mma.prnewswire.com/media/2461303/YBH_Logo.jpg